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Identification and characterization of a Mycoplasma hyopneumoniae
adhesin.
Abstract
An adhesin of Mycoplasma hyopneumoniae was identified and characterized in this study. A monoclonal
antibody (MAb), F2G5, and its F(ab')2 fragments inhibited the adherence of M. hyopneumoniae to porcine
tracheal cilia, the natural targets to which the mycoplasma binds during infection. MAb F2G5 detected
multiple bands, but predominantly recognized a 97-kDa (P97) protein of M. hyopneumoniae on
immunoblots. Affinity chromatography, conducted with immobilized MAb F2G5, mainly purified P97. The
purified proteins were able to bind to cilia and blocked the adherence of intact M. hyopneumoniae cells to
cilia. Immunolabeling of mycoplasmas with MAb F2G5 under electron microscopy demonstrated that the
proteins recognized by MAb F2G5 were located at the surface of the mycoplasma, predominantly on a surface
fuzzy layer. These results indicate that P97 functions as an adhesin of M. hyopneumoniae. The N-terminal
amino acid sequence of P97 did not have significant homology with any known bacterial or mycoplasmal
adhesins, suggesting that P97 is a novel protein. The predominant proteins detected by MAb F2G5 in
different strains varied in size, indicating that the antigen bearing the epitope for MAb F2G5 undergo
intraspecies size variation. Antigenic variation of adhesins may be a pathogenic mechanism utilized by M.
hyopneumoniae to evade the porcine immune system.
Disciplines
Veterinary Microbiology and Immunobiology | Veterinary Pathology and Pathobiology | Veterinary
Preventive Medicine, Epidemiology, and Public Health
Comments
This article is published as Zhang, Qijing, Theresa F. Young, and R. F. Ross. "Identification and
characterization of a Mycoplasma hyopneumoniae adhesin." Infection and Immunity 63, no. 3 (1995):
1013-1019. Posted with permission.
This article is available at Iowa State University Digital Repository: http://lib.dr.iastate.edu/vmpm_pubs/174
INFECTION AND IMMUNITY, Mar. 1995, p. 1013–1019 Vol. 63, No. 3
0019-9567/95/$04.0010
Copyright q 1995, American Society for Microbiology
Identification and Characterization of a Mycoplasma
hyopneumoniae Adhesin
QIJING ZHANG, THERESA F. YOUNG, AND R. F. ROSS*
Veterinary Medical Research Institute, Iowa State University, Ames, Iowa 50011
Received 9 August 1994/Returned for modification 5 October 1994/Accepted 15 December 1994
An adhesin of Mycoplasma hyopneumoniae was identified and characterized in this study. A monoclonal
antibody (MAb), F2G5, and its F(ab*)2 fragments inhibited the adherence of M. hyopneumoniae to porcine
tracheal cilia, the natural targets to which the mycoplasma binds during infection. MAb F2G5 detected
multiple bands, but predominantly recognized a 97-kDa (P97) protein of M. hyopneumoniae on immunoblots.
Affinity chromatography, conducted with immobilized MAb F2G5, mainly purified P97. The purified proteins
were able to bind to cilia and blocked the adherence of intact M. hyopneumoniae cells to cilia. Immunolabeling
of mycoplasmas with MAb F2G5 under electron microscopy demonstrated that the proteins recognized by MAb
F2G5 were located at the surface of the mycoplasma, predominantly on a surface fuzzy layer. These results
indicate that P97 functions as an adhesin ofM. hyopneumoniae. The N-terminal amino acid sequence of P97 did
not have significant homology with any known bacterial or mycoplasmal adhesins, suggesting that P97 is a
novel protein. The predominant proteins detected by MAb F2G5 in different strains varied in size, indicating
that the antigen bearing the epitope for MAb F2G5 undergo intraspecies size variation. Antigenic variation of
adhesins may be a pathogenic mechanism utilized by M. hyopneumoniae to evade the porcine immune system.
Mycoplasma hyopneumoniae is the etiological agent of my-
coplasmal pneumonia of swine, an economically important
swine disease. It is known thatM. hyopneumoniae colonizes the
respiratory epithelium of swine and produces a chronic pneu-
monia in pigs (20). During in vivo infection, the mycoplasmas
are intimately associated with the cilia of ciliated cells and
cause an extensive loss of cilia, as observed under an electron
microscope (3, 15, 22). There is a general notion that adher-
ence of M. hyopneumoniae to porcine respiratory ciliated cells
is a prerequisite for colonization of the organism on the respi-
ratory epithelium and development of pneumonia. Previous
studies have shown that the adherence process is mainly me-
diated by receptor-ligand interactions (36, 37, 39, 40). Several
carbohydrates inhibited the adherence of the mycoplasma to
cilia in a microtiter plate adherence assay, indicating that the
receptors in cilia were glycoconjugate in nature (36). A subse-
quent study by use of a thin-layer chromatography overlay
assay identified three ciliary glycolipid receptors for M. hyo-
pneumoniae in porcine ciliated cells (37).
The virulence factors of M. hyopneumoniae have not been
well defined. Several proteins of M. hyopneumoniae, including
a 36-kDa lactate dehydrogenase (11), membrane lipoproteins
(30), and a 54-kDa cytotoxic factor (10), have been character-
ized by different research groups; however, the biological func-
tions of these proteins in the pathogenesis have not been de-
termined. The adhesin(s) of M. hyopneumoniae has not been
identified. Previous studies showed that treatment of M. hyo-
pneumoniae with trypsin decreased adherence to single ciliated
cells and cell monolayers, indicating that the adhesin(s) of M.
hyopneumoniae might be a trypsin-sensitive protein (39, 40).
Identification and characterization of M. hyopneumoniae ad-
hesins will improve our understanding of the pathogenic mech-
anisms utilized by the organism and may lead to the develop-
ment of highly efficient measures for control of mycoplasmal
pneumonia of swine. In this study, monoclonal antibodies
(MAbs), affinity chromatography, electron microscopy, and
amino acid analysis were used along with an in vitro adherence
assay to elucidate an adhesin of M. hyopneumoniae.
MATERIALS AND METHODS
Mycoplasmas and culture conditions. M. hyopneumoniae LI27 was originally
derived from an experimentally infected pig. Strains 232 2A3 and 232 FA1 were
cloned from strain 232. Strain J was originally obtained from the American Type
Culture Collection and maintained in Friis mycoplasmal medium (9) in this
laboratory. Strain 144L was isolated in the laboratory from the lung of an
infected pig and filter-cloned three times. It was known that strains LI27, 232,
and 144L were pathogenic for pigs, whereas strain J was nonvirulent (38). In this
study, mycoplasmas were grown in Friis mycoplasmal medium supplemented
with 20% acid-adjusted swine serum. The cultures were incubated in a waterbath
shaker at 378C for 24 to 48 h. The number of mycoplasmas was estimated by the
determination of color-changing units (CCU). Mycoplasmas were harvested by
centrifugation at 25,000 3 g for 15 min. For adherence and adherence inhibition
assays, the mycoplasmal pellets were resuspended to 1/10 of the original volume
and further diluted with adherence buffer (RPMI 1640 containing 1% gelatin) to
the appropriate CCU. For production of mycoplasmal proteins required for
affinity chromatography, the pellets were further washed three times with phos-
phate-buffered saline (PBS, pH 7.2) and resuspended in PBS to 1/100 of the
original volume.
MAbs and fragmentation. MAbs to various antigens of M. hyopneumoniae
were supplied by Barbara Erickson (Veterinary Medical Research Institute, Iowa
State University, Ames). For adherence inhibition, these MAbs in cell culture
supernatants were concentrated about 12 times with ammonium sulfate. MAb
F2G5, which inhibited the adherence of M. hyopneumoniae to porcine cilia, was
purified from ascites with the ImmunoPure immunoglobulin M (IgM) purifica-
tion kit (Pierce, Rockford, Ill.). The purified MAb F2G5 was resuspended in PBS
and stored at 2208C for affinity chromatography and fragmentation. Fragmen-
tation of MAb F2G5 was performed with immobilized pepsin as described before
(2) with some modifications. This digestion method generates mainly F(ab9)2
fragments from mouse IgM; essentially no (Fc)5m can be produced (2). Briefly, 2
mg of MAb F2G5 was applied to a Centricon 100 microconcentrator (Amicon,
Danvers, Mass.) and spun down at 4,000 3 g for 40 min at 48C. The retentate
containing the MAb was washed twice with IgM F(ab9)2 digestion buffer (10 mM
sodium acetate, 150 mM NaCl, 0.05% NaN3 [pH 4.5]) and finally resuspended in
1 ml of digestion buffer. A small column packed with 2 ml of pepsin-agarose
(Pierce) was equilibrated with 10 ml of the digestion buffer and warmed at 378C
for 5 min. Then 1 ml of MAb F2G5 was added to the column and incubated at
378C for 2 h. The digest was eluted with 4 ml of the digestion buffer. The eluate
was filtered with a Microsep 300 concentrator to remove nondigested IgM. The
filtrate was further concentrated with a Centricon 30 microconcentrator. The
retentate, mainly containing F(ab9)2 fragments, was washed twice with PBS and
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resuspended in 0.5 ml of PBS. F(ab9)2 fragments of MAb 80.1, an antibody
against a 64-kDa protein which did not inhibit the adherence of M. hyopneu-
moniae to porcine cilia, were prepared by a similar procedure.
Adherence and adherence inhibition. A microtiter plate adherence assay
(MPAA) was conducted as described previously (36). Briefly,M. hyopneumoniae
whole cells (2 3 108 CCU) or mycoplasmal proteins (10 mg/ml) resuspended in
adherence buffer were added to microtiter plates coated with sodium dodecyl
sulfate (SDS)-solubilized porcine tracheal cilia and incubated at 378C for 90 min.
The nonattached mycoplasmas or proteins were washed off the plates with PBS.
The mycoplasmas or mycoplasmal proteins attached to the plates were detected
by sequential addition of rabbit anti-M. hyopneumoniae hyperimmune antibodies
and goat anti-rabbit immunoglobulins conjugated with peroxidase. ABTS [2,29-
azinobis(3-ethylbenzthiazoline-6-sulfonic acid)] was finally added, and the opti-
cal density at 405 nm (OD405) was measured.
For inhibition assays, various MAbs or F(ab9)2 fragments were preincubated
with intact mycoplasmas at 378C for 60 min. Two washes with PBS were con-
ducted to remove unbound antibodies. The preincubated mycoplasmas were
added to cilia-coated plates, and adherence was measured as described above.
Percent inhibition was calculated as described previously (36). Adhesins purified
by MAb F2G5 affinity chromatography were evaluated for inhibition of the
adherence of intact mycoplasmal cells. For this purpose, cilia-coated wells of
microtiter plates were first incubated with the purified adhesin at 378C for 90
min. The adherence buffer was used as the noninhibitory control. After four
washes with PBS, intact M. hyopneumoniae cells were added to the wells and
incubated at 378C for 90 min. Four washes with PBS were performed to remove
nonattached mycoplasmas. The attached mycoplasmas were sequentially de-
tected with a monospecific rabbit antiserum (R409) against a 64-kDa surface
protein of M. hyopneumoniae (34) and goat anti-rabbit immunoglobulin conju-
gated with peroxidase. It was determined in a preliminary experiment that an-
tiserum R409 did not cross-react with the purified adhesins but reacted with
whole cells of the mycoplasmas.
Immunoelectron microscopy. Immunolabeling of mycoplasmas with MAbs
was performed as described previously (1). Briefly, M. hyopneumoniae cells
resuspended in PBS containing 1% gelatin were incubated with 1:10-diluted
MAb F2G5 at 378C for 1 h. Mycoplasmas incubated with cell culture medium
were used as negative controls. The mycoplasmas were washed three times with
PBS and then reacted with 1:10-diluted goat anti-mouse IgM (m-chain specific)
conjugated with gold (10 nm; Sigma) at 378C for 1 h. After three washes with
PBS, the mycoplasmas were fixed with 3% glutaraldehyde-cacodylate buffer,
dehydrated in acetone, and embedded in epoxy resin. Thin sections were stained
with uranyl acetate and lead citrate and observed under a Hitachi H500 electron
microscope.
Comparison of different strains for adherence activities. Various strains ofM.
hyopneumoniae were cultured in Friis mycoplasmal medium, harvested by cen-
trifugation, and washed with PBS as described above. The protein concentration
of each strain was adjusted to 25 mg/ml for the adherence assay. The protein
profiles of different strains were analyzed by SDS-polyacrylamide gel electro-
phoresis (PAGE) and by immunoblotting with MAb F2G5.
SDS-PAGE and immunoblotting. SDS-PAGE was performed by the method
of Laemmli (13), with a 10% separating gel and 4% stacking gel. Mycoplasmas
or mycoplasmal proteins were mixed with equal volumes of treatment buffer
(0.125 M Tris-HCl [pH 6.8], 4% SDS, 20% glycerol, 10% 2-mercaptoethanol)
and heated at 1008C for 3 min prior to electrophoresis. The separated proteins
were visualized by staining the gels with Coomassie brilliant blue R-250. For
immunoblotting, proteins on the gels were transferred to nitrocellulose mem-
branes as described by Towbin et al. (23). The membranes were blocked with 3%
bovine serum albumin–0.1% Tween 20 in PBS at 258C for 60 min with gentle
shaking. Then, the blots were incubated with 1:100-diluted MAb F2G5 at 258C
for 2 h. After three washes with PBS containing 0.01% Tween 20, the blots were
further reacted with 1:1,000-diluted goat anti-mouse immunoglobulins conju-
gated with peroxidase at 258C for 2 h. Three washes were performed prior to
color development with 4-chloro-1-naphthol.
Antibody affinity chromatography. MAb F2G5 was coupled to Affi-Gel 10
(Bio-Rad Laboratories, Melville, N.Y.) according to the instructions supplied
with the activated support. In brief, 6 mg of purified MAb F2G5 resuspended in
4.5 ml of coupling buffer (0.1 M HEPES [N-2-hydroxyethylpiperazine-N9-2-
ethanesulfonic acid, pH 7.5]) was mixed with 3 ml of Affi-Gel 10. This mixture
was incubated at 48C for 4 h with gentle shaking. Then, 0.5 ml of 1 M ethanol-
amine HCl (pH 8.0) was added and incubated at 48C for 1 h to stop the coupling.
The gel was alternatively washed with 0.1 M Tris-HCl (pH 7.5) and the coupling
buffer. After packing into a small column, the gel was washed sequentially with
20 volumes of 10 mM Tris-HCl and 20 volumes of PBS containing 40 mM
CHAPS (3-[(3-cholamidopropyl)-dimethyllammonio]-1-propanesulfonate). My-
coplasmas resuspended in PBS containing 0.2 mM phenylmethylsulfonyl fluoride
were solubilized with 40 mM CHAPS at 48C for 1 h. The lysate was ultracentri-
fuged at 100,000 3 g for 30 min. The supernatant, containing solubilized myco-
plasmal proteins, was harvested. Preliminary experiments showed that adhesins
of M. hyopneumoniae were efficiently solubilized by CHAPS. Three milliliters of
the supernatant, containing 12 mg of mycoplasmal proteins, was applied to the
column and reacted at 48C overnight. Unbound proteins were washed off the
column with 50 ml of PBS containing 40 mM CHAPS. The proteins captured by
the antibody were eluted with 0.1 M glycine-HCl (pH 2.5). The eluate was
immediately neutralized to pH 7.5 with 1 M Tris and concentrated to 1 ml with
a Centricon 10. The purity of the proteins was determined by SDS-PAGE and
immunoblotting; the adherence activity of the eluted proteins was evaluated in
the MPAA; and the purified proteins were also used to block the adherence of
intact M. hyopneumoniae cells as described above.
Digestion of purified adhesins with trypsin. The controlled digestion of puri-
fied adhesins was performed as described previously (18). In brief, the adhesins
purified by MAb F2G5 were digested with various concentrations of trypsin (0.08
to 2.0 mg/ml) at 378C for 30 min. The digested adhesins were immediately mixed
with the treatment buffer and boiled at 1008C for 3 min. The samples from each
digestion were pooled and subjected to SDS-PAGE and immunoblotting with
MAb F2G5 as described above.
Protein sequencing and amino acid analysis. The N-terminal sequence of P97
was determined as described previously (14). The adhesins purified by MAb
F2G5 affinity chromatography were further separated by SDS-PAGE as de-
scribed above. After electrophoresis was completed, the gel was washed three
times with the transfer buffer [10 mM 3-(cyclohexylamino)-1-propanesulfonic
acid, 10% methanol (pH 11)]. The proteins on the gel were electroblotted to a
polyvinylidene difluoride (PVDF) Immobilon-P membrane (Millipore) at 50 mA
for 60 min. After being rinsed with distilled water, the membrane was stained
with 0.1% Coomassie brilliant blue R-250 for 5 min. Destaining was conducted
with a solution of 50% methanol and 10% acetic acid. Finally, the PVDF
membrane was thoroughly washed with distilled water and air dried. The mem-
brane was submitted to the Protein Facility at Iowa State University, where P97
was excised from the membrane and subjected to automatic Edman degradation
with an Applied Biosystems 477A liquid-pulse sequencer. For analysis of total
amino acid composition, P97 was excised from the PVDF membrane and ana-
lyzed with an Applied Biosystems 420 PTC amino acid analyzer.
RESULTS
Adherence inhibition by MAbs or MAb fragments. Various
MAbs were evaluated for the ability to inhibit the adherence of
M. hyopneumoniae to porcine cilia (Table 1). TwoMAbs, F2G5
and F1B6, inhibited adherence by up to 67% (Table 2). A
similar result was obtained when the hyperimmune serum used
for detection was replaced with antiserum R409 (a rabbit
monospecific antiserum to a 64-kDa surface protein of the
mycoplasma), indicating that the two MAbs indeed blocked
the adherence of mycoplasmas rather than the detection pro-
cess. As determined by immunoblotting, the two MAbs had
identical antigenic specificities, detected multiple bands, and
reacted predominantly with P97 (Fig. 1). Several other MAbs,
such as R6C10, I3A6, and F3D5, which also detected multiple
bands on immunoblots, did not inhibit the adherence (Table
1). The adherence-inhibiting activity was further evaluated
with F(ab9)2 fragments of MAb F2G5. Compared with the
adherence buffer, which was used as a negative control, the
F(ab9)2 fragments of MAb F2G5 produced 60% inhibition of
adherence of M. hyopneumoniae, while no inhibition resulted
with the F(ab9)2 of MAb 80.1 (data not shown).
Affinity chromatography. From 12 mg of starting material,
approximately 150 mg of protein was purified by MAb F2G5
affinity chromatography. SDS-PAGE showed that the predom-
inant protein captured by immobilized F2G5 from LI27 was
P97 (Fig. 2). Some faint bands were also present below P97.
These minor proteins also reacted with MAb F2G5. On im-
munoblots, the purified proteins reacted specifically with MAb
F2G5 (Fig. 2). Besides P97, a ladder of proteins was detected
by F2G5 in close proximity to P72. MAb F2G5 did not detect
P78 but did detect an 81-kDa protein in the purified materials
(Fig. 2). Purified P97 was diluted to 3.7, 7.5, 15, and 30 mg/ml
and evaluated for adherence activity in the MPAA. The results
showed that P97 adhered strongly to cilia and that this binding
was dose dependent. Nonspecific binding of P97 to the control
wells that were coated with gelatin or albumin was not de-
tected. Purified P97 also produced a dose-dependent inhibition
of the adherence of intact M. hyopneumoniae cells to cilia
(Table 3).
Tryptic digestion of purified adhesins. Treatment of P97
purified by antibody affinity chromatography yielded a ladder
1014 ZHANG ET AL. INFECT. IMMUN.
 o
n
 O
ctober 3, 2017 by IO
W
A STATE UNIVERSITY
http://iai.asm
.org/
D
ow
nloaded from
 
of peptides that reacted with F2G5 (Fig. 3). The minimum
resolvable fragment of trypsin-digested adhesins was approxi-
mately 20.5 kDa. As estimated by SDS-PAGE, the size differ-
ence between the peptides was approximately a multiple of 0.5
kDa.
Immunoelectron microscopy. M. hyopneumoniae cells were
reacted with F2G5 and goat anti-mouse IgM conjugated with
gold particles to determine the distribution of the adhesins on
mycoplasmas. MAb F2G5 stained the fuzzy surface structures
of M. hyopneumoniae (Fig. 4). The gold labeling was distrib-
uted randomly on the surface of mycoplasmas; it was not po-
larized at a specific region, as demonstrated with the P1 adhe-
sin of M. pneumoniae (12).
M. hyopneumoniae cells reacted with cell culture medium
and the conjugate were used as negative controls and did not
display any labeling with the gold particles (Fig. 4).
Strain variation in adherence. Five strains of M. hyopneu-
moniae differed markedly in adherence activity when evaluated
by the MPAA (Fig. 5). The adherence activity of strain J was
substantially lower than that of other strains, whereas strain
144L had the highest adherence activity among the five strains.
One of the major differences revealed by SDS-PAGE among
the five strains was in the regions detected by MAb F2G5 (Fig.
6). Immunoblotting with MAb F2G5 revealed that P97 was
missing in strain 144L and strain J, with the concomitant ap-
pearance of a 95-kDa protein in strain J and a doublet (93 and
92 kDa) in strain 144L that reacted with MAb F2G5 (Fig. 6).
Also, P72 was hardly detectable in strain J and disappeared in
strain 144L, but both strains J and 144L had an extra band
(approximately 69 kDa) that reacted with the MAb (Fig. 6).
N-terminal sequence and amino acid composition. Ex-
pressed in the single-letter code, the N-terminal sequence of
P97, beginning with alanine, was ADXKTDSDKDPSTLRA
IDEQ. The X in position 3 indicates an ambiguous residue.
This sequence was compared by the GCG program with all
FIG. 1. Antigenic specificity of MAbs. Total mycoplasmal proteins of strain
LI27 were separated by SDS-PAGE, transferred to a nitrocellulose membrane,
and reacted with MAbs F2G5 (lane 1), F1B6 (lane 2), and R6C10 (lane 3). Sizes
of proteins (in kilodaltons) are shown on the left.
FIG. 2. Purification of adhesins by antibody (MAb F2G5) affinity chroma-
tography. Lane 1, total mycoplasmal proteins (strain LI27); lane 2, eluate from
Affi-Gel 10 MAb F2G5 column (1.5 mg); lane 3, twofold-greater load of the
eluate. (A) SDS-PAGE profile stained with Coomassie brilliant blue R-250. (B)
immunostaining with MAb F2G5. Sizes of proteins (in kilodaltons) are shown on
the left and right of each panel.
TABLE 1. Adherence inhibition by various MAbs
MAb Isotype Specificitya Adherenceinhibitionb
80.1 IgM 64 2
A1B2 IgM 100 2
A2H10 IgG1 100 2
F1B6 IgM Multiplec 1
F2B11 IgG2a 86 2
F2G5 IgM Multiplec 1
F3A6 IgG2b 116 2
F3B8 IgG1 105, 95, 65, 55 2
F3D5 IgG1 105, 95, 65, 55 2
F3D6 IgG1 105, 95, 65, 55 2
I1D8 IgG1 116 2
I2E12 IgG1 86 2
I2E12 IgG1 86 2
I3A6 IgG1 200, 145, 140, 116, 86 2
I4A10 IgG1 70 2
I4A4 IgG1 100, 90, 80, 60, 50 2
I4B1 IgG1 41, 43 2
I4B10 IgG1 41 2
I4B2 IgG1 41 2
I4E3 IgG1 116 2
R1E9 IgG3 40 2
R2E8 IgG1 67 2
R3G7 IgG1 116 2
R4B2 IgG1 40 2
R4B7 IgG2a 116, 105, 90, 80, 65, 60, 55 2
R5F4 IgG1 116 2
R6C10 IgG2a 116, 105, 90, 80, 65, 60, 55 2
R6E1 IgG1 116, 40 2
R6E4 IgG2a 116, 105, 90, 80, 65, 60, 55 2
R6G8 IgG1 46 2
a Sizes of antigens (in kilodaltons) detected with strain LI27 on immunoblots.
Some MAbs detected antigens of varied sizes in different strains.
b 2, no inhibition detected with a 12-fold-concentrated culture supernatant;
1, produced dose-dependent inhibition.
c Reacted with a set of proteins with distinct sizes, but predominantly recog-
nized a 97-kDa protein.
TABLE 2. Adherence inhibition by MAbs F2G5, F1B6, and F3A6
Dilutiona
Mean % Inhibitionb 6 SD produced by MAb:
F3A6 F1B6 F2G5
1:2 211.9 6 3.1 67.0 6 5.1 66.2 6 4.5
1:10 2.5 6 2.2 45.9 6 3.4 58.7 6 5.0
1:50 211.1 6 6.5 210.8 6 6.1 29.5 6 3.7
1:250 21.1 6 2.4 29.7 6 8.0 13.0 6 4.1
aMAbs were concentrated approximately 12 times from the culture superna-
tant and further diluted in the adherence buffer.
bMean of three independent experiments.
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known protein and DNA sequences in the GenBank, EMBL,
and Swiss-Prot databases. No homology between this sequence
and the sequences of known bacterial or mycoplasmal adhesins
was detected. Analysis with Peptidestructure in the GCG se-
quence analysis software package predicted that this piece of
peptide of P97 was hydrophilic and surface exposed (data not
shown). The total amino acid composition of P97 was also
determined, and the molar ratios of various amino acids in P97
are shown in Table 4.
DISCUSSION
It was found in this study that (i) MAb F2G5, which recog-
nized a predominant 97-kDa protein in several strains of M.
hyopneumoniae, and its F(ab9)2 fragments inhibited the adher-
ence of M. hyopneumoniae to cilia; (ii) that purified P97 ad-
hered to cilia and blocked the adherence of intact M. hyopneu-
moniae cells; and (iii) MAb F2G5-reacting proteins were
located on the surface of M. hyopneumoniae. These findings
strongly indicate that P97 is an adhesin of M. hyopneumoniae.
Previous studies indicated that P97 was expressed during in
vivo infection and was one of the major immunogens of M.
hyopneumoniae (33, 35). In fact, P97 elicited a very early im-
mune response in the respiratory tract of swine, because IgA
and IgM antibodies to P97 were detected in the airway wash
samples of contact-exposed pigs 35 to 60 days earlier than
antibodies to other major immunogens of the mycoplasma
(33). Since P97 was only expressed by virulent M. hyopneu-
moniae and not by nonvirulent mycoplasmas, it had been pro-
posed that P97 might be one of the virulence-associated anti-
gens of M. hyopneumoniae, although the biological function of
P97 was unknown at that time (35). The results from this study
provided new evidence for the biological function of P97 in M.
hyopneumoniae infection. These findings strongly indicate that
P97 may be an important virulence factor of M. hyopneu-
moniae.
MAb F2G5 mainly stained the fuzzy structures on the sur-
face of M. hyopneumoniae, suggesting that the fuzzy structures
may be involved in the adherence of the mycoplasmas. It was
reported previously that the fuzz onM. hyopneumoniae bridges
the interaction between mycoplasmas and cilia (3, 22) and that
the fuzzy structures were observed with a pathogenic strain but
not with a strain that was nonadherent and nonpathogenic in
pigs (22). This evidence, together with the information gener-
ated from this study, strongly suggested that the fuzzy struc-
tures on M. hyopneumoniae play an important role in adher-
ence. The fuzz on the surface of streptococci, composed of M
proteins and lipoteichoic acid, is known to mediate the adher-
ence of streptococci to eucaryotic cells (6, 7, 25).
It is unlikely that the reactivity of MAb F2G5 to multiple
proteins was caused by impurity of the MAb. The hybridoma
cell line that secretes MAb F2G5 was subcloned by standard
procedures, and the secreted antibodies were detected as a
homogeneous IgM isotype. Also, MAb F1B6, which was pro-
duced by an independent hybridoma, had an antigenic speci-
ficity identical to that of F2G5. It is also unlikely that the
multiple reactivity was caused by the degradation of P97 during
the process of harvesting or SDS-PAGE, because inclusion of
a proteinase inhibitor (phenylmethylsulfonyl fluoride) during
the process did not change the reaction patterns of MAb
F2G5. It is believed that the reactivity of MAb F2G5 to mul-
tiple proteins was indeed due to the presence of the epitope in
multiple antigens. In fact, the expression of an epitope on
multiple proteins is common to many mycoplasma species,
such as M. hyorhinis (18, 19), M. pulmonis (28), M. hominis
(16), Ureaplasma urealyticum (27), and M. fermentans (31).
MAb F2G5 reacted with multiple proteins in a single strain
on immunoblots (Fig. 1) and recognized a different predomi-
nant protein in different strains (Fig. 6). Treatment of purified
P97 with trypsin under controlled conditions yielded multiple
peptide fragments that reacted with MAb F2G5 (Fig. 3). These
data clearly showed the heterogeneity of the putative adhesin
of M. hyopneumoniae. However, the relationships of these
MAb F2G5-reacting proteins or peptides were not revealed by
the data obtained from this study. It is our speculation that
these proteins may be size variants of a surface protein en-
coded by a gene with repetitive sequences. Molecular cloning
and sequencing of the gene for P97 will be required to verify
this hypothesis.
It was shown previously that different strains of M. hyopneu-
moniae vary in pathogenicity for pigs (38). Strains LI27, 144L,
232 2A3, and 232 FA1 were pathogenic, while strain J was
incapable of inducing pneumonia in pigs (33, 38). Also, no
mycoplasmas were isolated from the lungs of pigs inoculated
FIG. 3. Proteolysis of purified adhesins. The adhesins purified by antibody
affinity chromatography were digested with various doses of trypsin (0.08, 0.2,
0.5, and 2.0 mg/ml) as described in the text. Samples were pooled, separated by
SDS-PAGE, and immunoblotted with MAb F2G5. Lane 1, nondigested adhesins
(3 mg); lane 2, mixture of the adhesins (6 mg) digested with four different
concentrations of trypsin; lane 3, mixture of the adhesins (6 mg) digested with
trypsin at 0.2 and 0.5 mg/ml. Sizes of proteins (in kilodaltons) are indicated on the
left.
TABLE 3. Inhibition of M. hyopneumoniae adherence by
purified adhesins
Mycoplasmas
(CCU)
Mean adherencea 6 SD with indicated concn (mg/ml) of
purified adhesins
0.0 8 30 60
5 3 108 0.55 6 0.03 0.47 6 0.03 0.37 6 0.03b 0.24 6 0.02b
2 3 108 0.40 6 0.01 0.31 6 0.02b 0.20 6 0.02b 0.11 6 0.01b
8 3 107 0.21 6 0.01 0.15 6 0.01b 0.12 6 0.01b 0.07 6 0.01b
a Detected with a monospecific serum (R409) that did not react with P97. Data
are expressed as the mean OD of duplicate experiments.
b Significantly different from the controls without adhesins, as determined by
analysis of variance (P , 0.05).
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with strain J, indicating that this strain had lost the ability to
colonize the porcine respiratory epithelium (38). As shown in
Fig. 5, adherence to cilia differed among the five strains. It
appeared that the low adherence activity of strain J was cor-
related with its nonpathogenicity in pigs. However, this inter-
pretation should be made cautiously because these strains may
also vary in virulence traits other than adherence activity. Size
shifting of P97 was demonstrated in strains 144L and J (Fig. 6).
The effect of size variation of P97 on the adherence ability of
the mycoplasma remains to be determined in future studies.
P97 is unlikely to be a lipoprotein because P97 was not
extracted with Triton X-114 (data not shown). It was also
shown previously that M. hyopneumoniae only had four li-
poproteins, with molecular masses ranging from 44 to 65 kDa
(30), although a large number of lipid-modified proteins have
been found in other mycoplasma species (29, 32) and bacteria
FIG. 4. Transmission electron micrograph of mycoplasmas immunolabeled with MAb F2G5 and gold particles. (A) Mycoplasmas incubated with cell culture
medium and gold conjugates as a negative control. (B) Mycoplasmas reacted with MAb F2G5 and gold conjugates. Arrows indicate the fuzzy structures labeled with
gold particles. Bars, 0.1 mm.
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(21). Several mycoplasmal adhesins, such as P1 and P30 of M.
pneumoniae and P140 of M. genitalium, have considerable ho-
mology at both the protein and DNA levels (4, 5, 17). How-
ever, the N-terminal sequence of P97 did not have any homol-
ogy with known mycoplasmal adhesins. This result suggested
that P97 of M. hyopneumoniae might be distinct from other
mycoplasmal adhesins. In addition, this sequence may be use-
ful for cloning of the P97 gene in future studies. The absence
of cysteine and tryptophan residues in Table 4 does not nec-
essarily mean that there are no tryptophan or cysteine residues
in P97, because these two residues are labile to the acid hy-
drolysis step required for amino acid analysis (26). Also, the
regular procedure of amino acid analysis was not calibrated to
detect a lipid-modified cysteine. Since asparagine and glu-
tamine were deaminated to the corresponding carboxylic acids
(Asp and Glu, respectively) as a consequence of the acid hy-
drolysis step (26), the values for Asp and Glu (Table 4) rep-
resented a mixture of asparagine and aspartic acid and a mix-
ture of glutamine and glutamic acid, respectively. It will not be
possible to know the relative amount of each in the mixtures
until the full amino acid sequence of P97 has been determined.
P97 may not represent the only adhesin of M. hyopneu-
moniae, since MAb F2G5 and purified P97 did not completely
inhibit the adherence of M. hyopneumoniae to cilia. This is not
surprising, since pathogenic bacteria and mycoplasmas usually
have more than one adhesin. For example, M. pneumoniae has
two defined adhesins, P1 and P30 (17); a recent study sug-
gested that another surface protein (P90) was also involved in
the adherence of M. pneumoniae (8). Bordetella pertussis pos-
sesses four potential adhesins: filamentous hemagglutinin, per-
tussis toxin, pertactin, and fimbriae (24). These adhesins me-
diate the adherence of B. pertussis either to respiratory ciliated
cells or to macrophages (24). The interactions between the
multiple adhesins of an organism and the receptors on host
cells provide for increased adherence specificity and strength.
It is expected that more adhesins, other than those recognized
by MAb F2G5, of M. hyopneumoniae may be discovered in
future studies.
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